Holy Cross 9th Annual Winter Oncology Symposium

https://www.hconcologysymposium.com/

 

Future Directions in the Targeting of HER2+ Breast Cancer: duration of trastuzumab therapy

502 views
April 23, 2019
0 Comments
Login to view comments. Click here to Login